Showing 4 results for Retinopathy
Jamal Fallahty, Reza Rezaei, Saleh Astane, Fateme Marjan Mousavi,
Volume 13, Issue 3 (9-2010)
Abstract
Background: Diabetes is the sixth main cause of mortality in the world, and its both types are accompanied with eye complications in a way that the risk of blindness in diabetic patients is 25 times more than normal people. Hence, this study was conducted to determine diabetic patients’ awareness of the eye complications associated with this disease. Materials and Methods: In a cross-sectional study, 200 diabetic patients referring to the eye clinic of Amir Kabir Hospital of Arak in 2008 were evaluated. Data collection was done through questionnaire and referral interviews. Then some of the factors affecting patients’ awareness of eye complications associated with diabetes were analyzed. Results: The level of awareness of eye complications associated with diabetes in 40% of the patients was average. Also, significant relationships were observed between the level of awareness and age, job, education, type of retinopathy, type of treatment, and the history of referring to ophthalmologist (p<0.001), whereas no significant relationships were observed between the level of awareness and gender, familial history of diabetes, and controlling the diet (p>0.05). Conclusion: This study showed that a higher level of awareness in diabetic patients does not necessitate that they observe a proper diet, but it can lead to patients’ greater care in preventing the development of diabetes
Nasim Abbasi, Zivar Salehi, Yosef Alizadeh ,
Volume 17, Issue 9 (12-2014)
Abstract
Background: Diabetic retinopathy (DR) is a severe complication of diabetes and the leading cause of blindness among working adults worldwide. Chronic extra cellular hyperglycemia in diabetes stimulates reaction oxygen species (ROS) production and increase oxidative stress. Glutathion S- transferases (GSTs) enzymes have been shown to protect human from reactive oxygen compounds damage. The aim of the present study was to investigate whether the genetic polymorphism of GSTP1 is associated with DR.
Materials and Methods: This case–control study, included 70 patients with DR and 70 healthy volunteers. Genomic DNA was extracted from peripheral blood leukocytes. Genotypes were determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP). Statistical analysis was performed using the MedCalc program for Windows version 12.
Results: The prevalence of genotype frequencies of the GSTP1 Ile/Ile and Ile/Val were 71.42% and 28.57% respectively, in DR subject, whiles in healthy volunteers were 78.58% and 21.42%, respectively. Statistical analysis has not emerged significant difference from the comparison of either genotype (&Rho>0.05).
Conclusion: There was no evidence that GSTP1 variants were associated with DR in studied population. Further research is required to clarify role of GSTP1 in DR.
Sonya Zamani, Farhad Mashayekhi, Zivar Salehi, Nasim Abbasi,
Volume 18, Issue 11 (2-2016)
Abstract
Background: Diabetic retinopathy (DR) is the complication of diabetes mellitus (DM) and causes blindness among adults. Chronic extra cellular hyperglycemia in diabetes stimulates reaction oxygen species ROS production and increases oxidative stress. GPX-1 that was coded by GPX-1 gene is a key enzyme in protecting vessels against oxidative stress. The aim of this study was to evaluate the association of GPX-1 gene Pro 198 Leu polymorphism in patients with diabetic retinopathy.
Materials and Methods: In this case-control study, 160 blood samples of participants including 80 patients with diabetic retinopathy and 80 healthy individual were tested. Genotyping of GPX-1 gene was determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) by ApaI enzyme. Data analysis was performed using MedCalc (12.1) program.
Results: The genotype frequencies of the GPX-1 in DR patients for Leu/Leu, Leu/Pro, Pro/Pro were 10%, 62.5% and 27.5%, respectively, while for the control groups were 10%, 70% and 20%, respectively.In ohter words, Ile/Pro heterozygote was the most frequent genotype in patients and controls. According to the results of this study, there was not significant difference between patients with diabetic retinopathy and controls(p=0.52).
Conclusion: It is concluded that GPX-1 gene Pro 198 Leu polymorphism is not associated with DR. Further research is required to clarify the role of GPX-1 gene in DR in Rasht population along higher sample size.
Seyed Mohsen Madani Larijani, Zahra Salemi, Mohammad Reza Rezvanfar, Pegah Mohaghegh,
Volume 25, Issue 5 (12-2022)
Abstract
Introduction: Fetuin-A is a secreted protein from the liver, which plays a role in microvascular disorders of diabetes through insulin resistance and inflammation. The aim of this study is to investigate the amount of fetuin-A in diabetic patients without and with microvascular disorders.
Methods: 90 people in 4 groups, diabetic control, nephropathy, retinopathy and retinopathy-nephropathy participated in this research. Data were analyzed using Kruskal-Wallis and Pearson correlation tests. Measurement of parameters including VEGF, interleukin 8 (IL-8), insulin, interleukin 6 (IL- 6) and Fatuin-A was done by ELISA method. The concentration of C-reactive protein (CRP) was measured by nephrometric method.
Ethical considerations: This study was conducted after the approval of the protocol in the research ethics committee and receiving the ethical code number IR.ARAKMU.REC.1400.250 and according to the Declaration of Helsinki.
Results: The obtained results showed that the correlation between fetuin-A and VEGF in the control group was not significant (p=0.234), in the nephropathy group it was significant (p<0.01), in the retinopathy group it was significant (p<0.01) and in the retinopathy group - Nephropathy was significant (p=0.032). Also, the correlation between fetuin-A and interleukin-6 in the nephropathy group is not significant (p=0.285), in the retinopathy group is not significant (p<.075), in the retinopathy group is not significant (p<0.059) and in the retinopathy-nephropathy group. It was insignificant (p=0.113). The correlation between fetuin-A interleukin 8 in the control group is not significant (p=0.592), in the nephropathy group (p=0.592), in the retinopathy group (p=0.314) and in the retinopathy-nephropathy group (p= 0.362). The correlation between Fetuin-A and the homeostatic model of insulin resistance was significant in all groups (p<0.01). Fetuin-A and VEGF levels in the three groups of nephropathy and retinopathy increased significantly compared to the control group. The amount of interleukin 6, interleukin 8 and homeostatic model of insulin resistance in nephropathy, retinopathy and retinopathy-nephropathy groups has increased significantly compared to the control group.
Conclusions: Because fetuin-A is directly related to insulin resistance and VEGF production, its control can have an effect in preventing and controlling the development of microvascular disorders, especially in the early stages of diabetes. Although the results showed that fetuin-A level has no significant relationship with inflammatory factors such as interleukin 6 and interleukin 8, especially in the retinopathy-nephropathy group, but a significant increase of interleukin 6, interleukin 8 and CRP in patients with microvascular disorders to the diabetic control group, it shows the importance of inflammation in the development and progression of microvascular disorders and the importance of its control in diabetic patients.
